Nucleotide sequence changes in E6, L1 (MY), and LCR regions from A1/2, D2 and D3 HPV16 variants. by Ana Alfaro (280118)

Subjects:

Decreased CCL2 levels protect A20^AEC-KO mice against influenza A infection by Jonathan Maelfait (181048)

siATF2 treatment decreases γ-globin gene expression in K562 cells. by Li Liu (75607)

rhIL-4 and rhIL-13 decrease LEC proliferation and downregulate expression of Prox-1. by Ira L. Savetsky (749034)

Wild-type SPOP increases, and the prostate cancer-associated SPOP mutants decrease, mitochondria average length. by Xiaofeng Jin (646436)

Activation of axonal GABA_A receptors decreases AP-induced Ca²⁺ transients. by Yang Xia (104600)

“…Data were collected from the axon trunk (n = 9 axons). D, PTX blocked GABA-induced decrease in Ca²⁺ transients. …”

Visual deprivation rescues the decrease in proliferative cells by HDAC1 knockdown. by Yi Tao (178829)

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…<p><b>(A)</b> Kaplan-Meier survival curve. Tamoxifen was given by gavage for 6 days to mice with the genotype <i>Mll1</i>^{<i>FC/+; Vil-Cre-ERT2/+</i>} (n = 12) and <i>Mll1</i>^{<i>FC/FC; RC/+</i>} (n = 18). …”

Iminosugar-based GCS inhibitors decrease brain α-synuclein aggregates. by Karen M. Ashe (349018)

Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Oligomycin decreases proteasome inhibition-induced cell death in the presence of Ade. by Shujue Li (466324)

Reductions in MEF2 expression do not impair PGE₂ decrease of <i>Sost</i>. by Damian C. Genetos (325684)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”

Animals lacking HP1B show decreased levels of activity. by Benjamin B. Mills (5879504)

Down-regulation of Gli decreased ovarian cancer cell migration and invasion. by Qi Chen (144168)

“…(<b>C, D</b>) GANT61 inhibits expression of Gli2 in ovarian cancer cells. …”

Decreased expression of antioxidant genes in the RPE in XBP1 KO mice. by Yimin Zhong (159151)

Over-expression of rhodopsin decreased the expression levels of differentiation markers in NHEKs. by Hyoung-June Kim (459814)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)